BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3367313)

  • 1. Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid.
    Van Wauwe JP; Coene MC; Goossens J; Van Nijen G; Cools W; Lauwers W
    J Pharmacol Exp Ther; 1988 May; 245(2):718-22. PubMed ID: 3367313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
    Van Wauwe J; Van Nyen G; Coene MC; Stoppie P; Cools W; Goossens J; Borghgraef P; Janssen PA
    J Pharmacol Exp Ther; 1992 May; 261(2):773-9. PubMed ID: 1374473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats.
    Van Wauwe JP; Coene MC; Goossens J; Cools W; Monbaliu J
    J Pharmacol Exp Ther; 1990 Jan; 252(1):365-9. PubMed ID: 2299598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome-P-450-dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole.
    Vanden Bossche H; Willemsens G; Janssen PA
    Skin Pharmacol; 1988; 1(3):176-85. PubMed ID: 2856164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.
    von Moltke LL; Greenblatt DJ; Harmatz JS; Duan SX; Harrel LM; Cotreau-Bibbo MM; Pritchard GA; Wright CE; Shader RI
    J Pharmacol Exp Ther; 1996 Feb; 276(2):370-9. PubMed ID: 8632299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 13-cis-retinoic acid by a rat liver 9000g supernatant preparation.
    Vane FM; Buggé CJ; Williams TH
    Drug Metab Dispos; 1982; 10(3):212-9. PubMed ID: 6125352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the in vivo and in vitro metabolism of retinoic acid.
    Roberts AB; Frolik CA
    Fed Proc; 1979 Oct; 38(11):2524-7. PubMed ID: 488375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of retinoic acid on hepatic cytochrome P-450 dependent enzymes in rats under different vitamin A status.
    Periquet B; Periquet A; Bailly A; Ghisolfi J; Thouvenot JP
    Int J Vitam Nutr Res; 1986; 56(3):223-9. PubMed ID: 3781745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
    Shirley MA; Bennani YL; Boehm MF; Breau AP; Pathirana C; Ulm EH
    Drug Metab Dispos; 1996 Mar; 24(3):293-302. PubMed ID: 8820419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
    Remmel RP; Crews BC; Kozak KR; Kalgutkar AS; Marnett LJ
    Drug Metab Dispos; 2004 Jan; 32(1):113-22. PubMed ID: 14709628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of 7,8-dihydrobenzo(a)pyrene by rat liver microsomal enzymes and mutagenicity of metabolites.
    Chiu PL; Yang SK
    Cancer Res; 1986 Oct; 46(10):5084-94. PubMed ID: 3756866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liarozole fumarate inhibits the metabolism of 4-keto-all-trans-retinoic acid.
    Van Wauwe J; Coene MC; Cools W; Goossens J; Lauwers W; Le Jeune L; Van Hove C; Van Nyen G
    Biochem Pharmacol; 1994 Feb; 47(4):737-41. PubMed ID: 8129749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.
    Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Benet LZ; Sewing KF; Christians U
    Drug Metab Dispos; 1999 Feb; 27(2):173-9. PubMed ID: 9929499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
    Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoconazole inhibits cyclosporine metabolism in vivo in mice.
    Anderson JE; Blaschke TF
    J Pharmacol Exp Ther; 1986 Mar; 236(3):671-4. PubMed ID: 3950868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of 6-methylbenz[a]anthracene by rat liver microsomes and mutagenicity of metabolites.
    Mushtaq M; Fu PP; Miller DW; Yang SK
    Cancer Res; 1985 Sep; 45(9):4006-14. PubMed ID: 3896475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of ketoconazole-induced elevation of individual serum bile acids in the rat: relationship to the effect of ketoconazole on bile acid uptake by isolated hepatocytes.
    Azer SA; Kukongviriyapan V; Stacey NH
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1231-7. PubMed ID: 7891338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors.
    Krekels MD; Zimmerman J; Janssens B; Van Ginckel R; Cools W; Van Hove C; Coene MC; Wouters W
    Prostate; 1996 Jul; 29(1):36-41. PubMed ID: 8685053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.